Mutations in the IDH1 and IDH2 genes have been found in various tumor types and catalyze reduction of a-KG into a structurally similar oncometabolite 2-hydroxyglutarate (2-HG), which probably functions as an α-KG antagonist in numerous metabolic processes1,2. Here, IDH2 is linked to neoplasm.